RedHill Biopharma annual total assets
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
RedHill Biopharma Total Assets Growth & History (RDHL)
RedHill Biopharma's total assets was $25.3M for fiscal 2025.
View full RedHill Biopharma company overviewRedHill Biopharma annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $25.3M | $7.3M | +40.47% |
| 2024 | 2024-12-31 | $18.0M | −$5.0M | −21.71% |
| 2023 | 2023-12-31 | $23.0M | −$135.8M | −85.49% |
| 2022 | 2022-12-31 | $158.9M | −$22.3M | −12.32% |
| 2021 | 2021-12-31 | $181.2M | $947,000 | +0.53% |
| 2020 | 2020-12-31 | $180.2M | $106.1M | +143.24% |
| 2019 | 2019-12-31 | $74.1M | $11.7M | +18.73% |
| 2018 | 2018-12-31 | $62.4M | $5.1M | +8.84% |
| 2017 | 2017-12-31 | $57.3M | −$16.9M | −22.73% |
| 2016 | 2016-12-31 | $74.2M | — | — |
RedHill Biopharma quarterly total assets
Q4.16
Q4.17
Q2.18
Q4.18
Q2.19
Q4.19
Q2.20
Q4.20
Q2.21
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $25.3M | $7.3M | +40.47% |
| Q2 2025 | 2025-06-30 | $18.4M | −$3.6M | −16.57% |
| Q4 2024 | 2024-12-31 | $18.0M | −$5.0M | −21.71% |
| Q2 2024 | 2024-06-30 | $22.0M | −$13.0M | −37.14% |
| Q4 2023 | 2023-12-31 | $23.0M | −$135.8M | −85.49% |
| Q2 2023 | 2023-06-30 | $35.0M | −$132.9M | −79.14% |
| Q4 2022 | 2022-12-31 | $158.9M | −$22.3M | −12.32% |
| Q2 2022 | 2022-06-30 | $168.0M | −$35.7M | −17.53% |
| Q4 2021 | 2021-12-31 | $181.2M | $947,000 | +0.53% |
| Q2 2021 | 2021-06-30 | $203.7M | $37.3M | +22.42% |
| Q4 2020 | 2020-12-31 | $180.2M | $106.1M | +143.24% |
| Q2 2020 | 2020-06-30 | $166.4M | $116.7M | +234.78% |
| Q4 2019 | 2019-12-31 | $74.1M | $11.7M | +18.73% |
| Q2 2019 | 2019-06-30 | $49.7M | $11.8M | +31.30% |
| Q4 2018 | 2018-12-31 | $62.4M | $5.1M | +8.84% |
| Q2 2018 | 2018-06-30 | $37.8M | — | — |
| Q4 2017 | 2017-12-31 | $57.3M | −$16.9M | −22.73% |
| Q4 2016 | 2016-12-31 | $74.2M | — | — |
RedHill Biopharma total assets trends
Over the last five fiscal years, RedHill Biopharma's total assets decreased from $180.2M to $25.3M, a change of −$154.9M. The latest reported quarter, Q4 2025, shows $25.3M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review RedHill Biopharma source filings ↗